After a careful analysis of the pending impact of the Inflation Reduction Act on Medicare Prescription Drug Plans (PDPs), Mutual of Omaha Rx has made the strategic decision to exit the Medicare Prescription Drug Plan market at the end of 2024.
As a leading provider of Medicare Supplement insurance for more than 50 years, they remain fully committed to offering valuable solutions to senior health customers, including Medicare Supplement, dental and vision coverage, as well as their co-branded Medicare Advantage PPO plans with Wellcare.
They are also discontinuing marketing of their Mutual of Omaha Rx Prescription Drug Plans, effective immediately to prevent further customer disruption.
Mutual of Omaha remains committed to offering a variety of valuable solutions to senior health customers, including Medicare supplement, dental, and vision coverage, as well as our new co-branded Medicare Advantage PPO plans with Wellcare.